Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Urinary Bladder Neoplasms × Enoxaparin × Clear all

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Venous Thrombosis 2 Venous Thromboembolism 2 Pulmonary Embolism 2 Neoplasms 2 Urinary Bladder Neoplasms 1 Thrombosis 1 Thromboembolism 1 Stroke 1 Soft Tissue Neoplasms 1 Sarcoma 1 Multiple Myeloma 1 Lymphoma 1 Leukemia 1 Hemorrhage 1 Hematologic Neoplasms 1 Anastomotic Leak 1

Interventions

Standard of Care 8 Cystectomy 8 Early Intervention, Educational 6 Cystoscopy 6 Transurethral Resection of Bladder 4 Practice Guidelines as Topic 4 Multiparametric Magnetic Resonance Imaging 4 Methods 4 Blood Specimen Collection 4 Anesthesia, General 4 Surgical Procedures, Operative 3 Sevoflurane 3 Radiotherapy, Intensity-Modulated 3 Gemcitabine 3 Exercise 3 Cisplatin 3 Anesthesia, Spinal 3 Watchful Waiting 2 Specimen Handling 2 Saline Solution 2 Robotic Surgical Procedures 2 Radiotherapy 2 Psychiatric Rehabilitation 2 Propofol 2 Preoperative Exercise 2 Palliative Care 2 Optical Imaging 2 Neoadjuvant Therapy 2 Magnetic Resonance Spectroscopy 2 Magnetic Resonance Imaging 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06243510 2026-01-28

CARE

Abramson Cancer Center at Penn Medicine

Phase NA Enrolling by invitation

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡